Bon appetit: Cellectis CEO Choulika hosts a gene-edited feast; CRO Medpace adding 650 staffers
Cellectis CEO André Choulika loves nothing better than celebrating the pioneering work he’s planning to do with gene editing and next-gen CAR-T. But he also runs an ag bio outfit called Calyxt which plans to bring the gene editing revolution into the food supply. And what better way to highlight that work than the world’s first feast involving gene-edited foods. According to the PR, the dinner in New York required “a six-month preparation time entrusted to The Lab-Ducasse Conseil’s chefs and experts with a series of trials where the ingredients were cooked and tasted in a variety of ways. Attendees included university professors, doctors, reporters, celebrities, entrepreneurs and key opinion leaders.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.